Printer Friendly

STI ANNOUNCES APPOINTMENT OF EXECUTIVE DIRECTOR, COMMERCIAL DEVELOPMENT

 STI ANNOUNCES APPOINTMENT
 OF EXECUTIVE DIRECTOR, COMMERCIAL DEVELOPMENT
 ROCKVILLE, Md., May 20 /PRNewswire/ -- Survival Technology, Inc., (NASDAQ-NMS: SURV) announced today the appointment of Frank J. Massino to the newly created position of executive director, commercial development. He will be responsible for all U.S. marketing and sales activities for the company's pharmaceutical delivery systems. Massino was previously director of business development and strategic planning for Ortho Pharmaceutical Corporation, a division of Johnson & Johnson.
 STI President James H. Miller said: "We are very pleased to have Frank Massino on board. He has more than 20 years of experience in pharmaceutical marketing and sales, including product management, business development and strategic planning."
 Prior to Ortho, Massino worked for Glaxo, Inc., and the J.B. Roerig Division of Pfizer, Inc. He is a native of Toluca, Ill., and holds a B.A. in finance and chemistry from the University of Illinois.
 STI is a technology-based health care company that designs, develops and produces automatic injectors, prefilled syringes and medical electronics, with major focus on safe and convenient participation by the patient in injection therapy. The company also supplies delivery system design, pharmaceutical research and development and sterile product manufacturing to major pharmaceutical companies worldwide.
 -0- 5/20/92
 /CONTACT: Doris L. Geier, director, human resources; or Kathleen Austin, marketing, Survival Technology, 301-926-1800/
 (SURV) CO: Survival Technology, Inc. ST: Maryland IN: MTC SU: PER


DS -- DC010 -- 2224 05/20/92 09:52 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 20, 1992
Words:239
Previous Article:PEORIA (ARIZ.) IMPROVEMENT DISTRICT 8801 BONDS RATED 'BBB+' BY FITCH -- FITCH FINANCIAL WIRE --
Next Article:RHONE-POULENC RORER REPORTS CONTINUED STRONG GROWTH IN EARNINGS: ACHIEVING ADDITIONAL EFFICIENCIES AND CREATING STRATEGIC PARTNERSHIPS
Topics:


Related Articles
SURVIVAL TECHNOLOGY UPDATES ITS OPERATING NAME TO REFLECT EXPANDING COMMERCIAL PRODUCTS FOCUS
STI STRENGTHENS PRODUCT LINE, GLOBAL REACH TO BETTER POSITION FOR LONG-TERM GROWTH
STI REPORTS CONTINUED EARNINGS FOR ITS FISCAL 1993 THIRD QUARTER
STI LICENSES NEW PAIN PRODUCT TO LOTUS FOR HOME HEALTH CARE
J. MILLER ASSUMES ADDITIONAL POST AS CHAIRMAN, PRESIDENT AND CEO OF BRUNSWICK BIOMEDICAL
STI INTERNATIONAL ENTERS AGREEMENT FOR NEW MILITARY AUTO-INJECTOR PRODUCT
SURVIVAL TECHNOLOGY, INC. ANNOUNCES SALE OF MEDICAL DEVICE DIVISION TO BRUNSWICK BIOMEDICAL CORPORATION
STI ELECTS G. WICKES AND J. CHURCH SR. V.P.; C. D'ERASMO NAMED TREASURER, M. SMITH DIV. V.P.
STI RECEIVES FDA APPROVAL FOR NEW AUTO-INJECTOR PRODUCT
STI ELECTS J. MILLER CHAIRMAN OF BOARD

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters